NasdaqCM - Delayed Quote • USD
Qualigen Therapeutics, Inc. (QLGN)
At close: April 23 at 4:00 PM EDT
Pre-Market: 8:54 AM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-10,304.2630
-10,304.2630
-13,247.5410
-14,730.7420
Investing Cash Flow
4,215.9430
4,215.9430
-183.7630
-141.3640
Financing Cash Flow
-550.0000
-550.0000
2,910.5150
8,433.8080
End Cash Position
401.8030
401.8030
3,165.9850
17,538.2720
Income Tax Paid Supplemental Data
5.5710
5.5710
5.5710
5.1330
Interest Paid Supplemental Data
--
--
--
1.2330
Capital Expenditure
--
--
-319.1170
-141.3640
Issuance of Capital Stock
--
--
--
8,820.0000
Issuance of Debt
--
--
2,903.8470
--
Repayment of Debt
-550.0000
-550.0000
--
-138.7390
Repurchase of Capital Stock
--
--
-0.5050
--
Free Cash Flow
-10,304.2630
-10,304.2630
-13,247.5410
-14,872.1060
12/31/2021 - 6/23/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MRZM Marizyme, Inc.
0.0950
0.00%
VCNX Vaccinex, Inc.
4.9631
+3.40%
TMBRQ Trex Wind-down, Inc.
0.0002
+100.00%
ARTL Artelo Biosciences, Inc.
1.3100
+0.77%
QNRX Quoin Pharmaceuticals, Ltd.
0.6600
0.00%
FBRX Forte Biosciences, Inc.
0.7386
+2.58%
NBY NovaBay Pharmaceuticals, Inc.
0.0770
+6.21%
CYTO Altamira Therapeutics Ltd.
1.5800
+12.86%
4OR1.BE Organovo Holdings Inc
0.9300
-1.90%
DRMA Dermata Therapeutics, Inc.
0.3397
+0.32%